NO20063861L - 2-(3-substituert aryl)amin-4-arylthiazoler som tyrosinkinasehemmere - Google Patents

2-(3-substituert aryl)amin-4-arylthiazoler som tyrosinkinasehemmere

Info

Publication number
NO20063861L
NO20063861L NO20063861A NO20063861A NO20063861L NO 20063861 L NO20063861 L NO 20063861L NO 20063861 A NO20063861 A NO 20063861A NO 20063861 A NO20063861 A NO 20063861A NO 20063861 L NO20063861 L NO 20063861L
Authority
NO
Norway
Prior art keywords
arylthiazoles
substituted aryl
disorders
amine
tyrosine kinase
Prior art date
Application number
NO20063861A
Other languages
English (en)
Inventor
Camille Wermuth
Alain Moussy
Marco Ciufolini
Bruno Giethlen
Original Assignee
Ab Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Science filed Critical Ab Science
Publication of NO20063861L publication Critical patent/NO20063861L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

Den foreliggende oppfinnelsen gjelder nye forbindelser utvalgt blant 2-(3-substituert aryl)amino-4-aryltiazoler som selektivt modulerer, regulerer og/eller inhiberer signaloverføring formidlet av visse native og/eller mutante tyrosinkinaser som deltar i en rekke forskjellige sykdommer hos mennesker og dyr så som celleproliferative lidelser, metabolske lidelser, allergiske lidelser og degenerative lidelser. Nærmere bestemt er disse forbindelsene kraftige og selektive c-kit-inhibitorer.
NO20063861A 2004-01-30 2006-08-30 2-(3-substituert aryl)amin-4-arylthiazoler som tyrosinkinasehemmere NO20063861L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54006404P 2004-01-30 2004-01-30
PCT/IB2005/000401 WO2005073225A1 (en) 2004-01-30 2005-01-28 2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors

Publications (1)

Publication Number Publication Date
NO20063861L true NO20063861L (no) 2006-10-23

Family

ID=34826177

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063861A NO20063861L (no) 2004-01-30 2006-08-30 2-(3-substituert aryl)amin-4-arylthiazoler som tyrosinkinasehemmere

Country Status (12)

Country Link
EP (1) EP1711497A1 (no)
JP (1) JP2007519711A (no)
KR (1) KR20060129413A (no)
CN (1) CN1934107A (no)
AU (1) AU2005209485A1 (no)
BR (1) BRPI0507271A (no)
CA (1) CA2554925A1 (no)
IL (1) IL177007A0 (no)
NO (1) NO20063861L (no)
NZ (1) NZ548884A (no)
WO (1) WO2005073225A1 (no)
ZA (1) ZA200606152B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008540537A (ja) 2005-05-09 2008-11-20 アキリオン ファーマシューティカルズ，インコーポレーテッド チアゾール化合物および使用方法
US20060281788A1 (en) 2005-06-10 2006-12-14 Baumann Christian A Synergistic modulation of flt3 kinase using a flt3 inhibitor and a farnesyl transferase inhibitor
DK2021335T3 (da) 2006-04-20 2011-09-05 Janssen Pharmaceutica Nv Heterocykliske forbindelser som C-FMS-kinasehæmmere
US8697716B2 (en) 2006-04-20 2014-04-15 Janssen Pharmaceutica Nv Method of inhibiting C-KIT kinase
WO2007124369A2 (en) * 2006-04-20 2007-11-01 Janssen Pharmaceutica N.V. Method of inhibiting c kit kinase
PE20080074A1 (es) 2006-04-20 2008-02-11 Janssen Pharmaceutica Nv Derivados de amida como agentes inhibidores de la quinasa c-fms
US7879856B2 (en) 2006-12-22 2011-02-01 Rigel Pharmaceuticals, Inc. Diaminothiazoles useful as Axl inhibitors
GB0701426D0 (en) * 2007-01-25 2007-03-07 Univ Sheffield Compounds and their use
EP2164846A2 (en) 2007-05-22 2010-03-24 Achillion Pharmaceuticals, Inc. Heteroaryl substituted thiazoles and their use as antiviral agents.
JO3240B1 (ar) 2007-10-17 2018-03-08 Janssen Pharmaceutica Nv c-fms مثبطات كيناز
WO2009114552A1 (en) * 2008-03-10 2009-09-17 The Board Of Trustees Of The Leland Stanford Junior University Heteroaryl compounds, compositions, and methods of use in cancer treatment
UA103319C2 (en) 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds
US8106209B2 (en) 2008-06-06 2012-01-31 Achillion Pharmaceuticals, Inc. Substituted aminothiazole prodrugs of compounds with anti-HCV activity
PT2387395E (pt) 2009-01-16 2015-02-04 Rigel Pharmaceuticals Inc Inibidores de axl para utilização em terapia de combinação para prevenir, tratar ou gerir cancro metastático
AU2012288900B2 (en) * 2011-07-27 2016-10-06 Ab Science Selective protein kinase inhibitors
CN103130792B (zh) * 2011-11-30 2016-05-04 正大天晴药业集团股份有限公司 一种2-氨基噻唑类化合物
US9290489B2 (en) 2012-07-06 2016-03-22 Duke University Activation of TRPV4 ion channel by physical stimuli and critical role for TRPV4 in organ-specific inflammation and itch
IN2015DN00659A (no) 2012-08-07 2015-06-26 Janssen Pharmaceutica Nv
JOP20180012A1 (ar) 2012-08-07 2019-01-30 Janssen Pharmaceutica Nv عملية السلفنة باستخدام نونافلوروبوتانيسولفونيل فلوريد
CN103254184B (zh) * 2013-05-27 2015-03-18 湖南科技大学 5-取代-3-[5-羟基-4-吡喃酮-2-基-甲硫基]-4-氨基-1,2,4-三唑类化合物及其用途
CN103319467B (zh) * 2013-06-15 2015-10-14 湖南科技大学 一种4-[5-羟基-4-吡喃酮-2-基亚甲氨基]-3-巯基-1,2,4-三唑化合物及用途
US10329265B2 (en) 2014-08-22 2019-06-25 Duke University TRPA1 and TRPV4 inhibitors and methods of using the same for organ-specific inflammation and itch
US11229628B2 (en) 2015-01-09 2022-01-25 Duke University TRPA1 and TRPV4 inhibitors and methods of using the same for organ-specific inflammation and itch
EP3439656A4 (en) 2016-04-07 2020-03-11 Duke University SMALL MOLECULAR DUAL INHIBITORS OF TRPV4 AND TRPA1 FOR DISINFECTING AND STUNNING
AU2020242287A1 (en) 2019-03-21 2021-09-02 INSERM (Institut National de la Santé et de la Recherche Médicale) A Dbait molecule in combination with kinase inhibitor for the treatment of cancer
WO2021089791A1 (en) 2019-11-08 2021-05-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the treatment of cancers that have acquired resistance to kinase inhibitors
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID24372A (id) * 1997-10-27 2000-07-13 Agouron Pharma SENYAWA-SENYAWA 4-AMINO-TIAZOL-2-IL SEBAGAI PENGHAMBAT-PENGHAMBAT CDKs
US6262096B1 (en) * 1997-11-12 2001-07-17 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
EP1169038B9 (en) * 1999-04-15 2013-07-10 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
HN2002000156A (es) * 2001-07-06 2003-11-27 Inc Agouron Pharmaceuticals Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización.
EP1418909B1 (en) * 2001-08-13 2013-02-20 Janssen Pharmaceutica NV 2-AMINO-4, 5-TRISUBSTITUTED THIAzOLYL DERIVATIVES AND THEIR USE AGAINST AUTOIMMUNE DISEASES
WO2003062215A1 (en) * 2002-01-25 2003-07-31 Kylix Pharmaceuticals B.V. 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2
BRPI0313165B8 (pt) * 2002-08-02 2021-05-25 Ab Science 2-(3-aminoaril)amino-4-aril-tiazóis e sua utilização como inibidores de c-kit
JP2006526656A (ja) * 2003-06-03 2006-11-24 ノバルティス アクチエンゲゼルシャフト ５員ヘテロ環ベースのｐ−３８阻害剤

Also Published As

Publication number Publication date
EP1711497A1 (en) 2006-10-18
WO2005073225A1 (en) 2005-08-11
NZ548884A (en) 2010-06-25
IL177007A0 (en) 2006-12-10
BRPI0507271A (pt) 2007-06-26
JP2007519711A (ja) 2007-07-19
ZA200606152B (en) 2007-11-28
CA2554925A1 (en) 2005-08-11
AU2005209485A1 (en) 2005-08-11
CN1934107A (zh) 2007-03-21
KR20060129413A (ko) 2006-12-15

Similar Documents

Publication Publication Date Title
NO20063861L (no) 2-(3-substituert aryl)amin-4-arylthiazoler som tyrosinkinasehemmere
NO20062308L (no) 2-aminoarykloksazolforbindelser som tyrosinkinasehemmere
NO20051115L (no) 2-(3-aminoaryl)amino-4-aryltiazoler og anvendelse derav som c-kit-inhibitorer
UA95071C2 (ru) Замещенные производные оксазола и их применение как ингибиторов тирозинкиназы
WO2007013896A3 (en) Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors
UA97816C2 (en) Compounds modulating c-kit and/or c-fms activity and use thereof
NO20075627L (no) Inhibitorer av cytosolisk fosfolipase A2
ATE381332T1 (de) Tyrosinkinase-hemmer
MXPA05010711A (es) Compuestos y composiciones novedosos como inhibidores de proteina-quinasa.
WO2008002571A3 (en) Human protein tyrosine phosphatase inhibitors and methods of use
WO2006064375A2 (en) Aminoaryl substituted five-membered ring heterocyclic compounds for the treatment of diseases
WO2008002569A3 (en) Human protein tyrosine phosphatase inhibitors and methods of use
NO20093009L (no) Kondensert ring heterocykel kinase modulatorer
MX2008001538A (es) Aril piridinas y metodos para su uso.
MX2022004937A (es) Inhibidores de las cinasas raf.
CY1110663T1 (el) 2-αμινοαρυλοξαζολικες ενωσεις ως παρεμποδιστες κινασων της τυροσινης
MY167575A (en) Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
NO20083045L (no) Benzimidazolderivater og deres anvendelse til modulering av GABAA-reseptorkomplekset
UA93679C2 (en) Compounds modulating c-kit and c-fms activity and uses therefor
CU23680B7 (es) Derivados de oxazol sustituidos y su uso como inhibidores de tirosina quinasa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application